MAILLET; Emeline

Patent Applications and Registrations

Patent applications and USPTO patent grants for MAILLET; Emeline.The latest application filed is for "methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids".

Company Profile

3.5.17

MAILLET; Emeline - Miami Beach FL
Maillet; Emeline - New Orleans LA
Maillet; Emeline - Miami FL
Maillet; Emeline - Fort Lauderdale FL
Maillet; Emeline - Bagneux FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloids App 20220193088 - WEIS; Holger ; et al.	2022-06-23
Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids Grant 11,260,059 - Weis , et al. March 1, 2	2022-03-01
Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids Grant 11,197,866 - Weis , et al. December 14, 2	2021-12-14
Methods And Compositions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloids App 20210299139 - WEIS; Holger ; et al.	2021-09-30
Methods And Compositions For Reducing Tolerance To Opioid Analgesics Using Ibogaine And Derivatives Thereof App 20210290634 - MAILLET; Emeline ; et al.	2021-09-23
Methods and compositions for ibogaine treatment of impulse control disorder, anxiety-related disorders, violence and/or anger, or regulating food intake Grant 11,077,118 - Maillet August 3, 2	2021-08-03
Methods For Acute And Long-term Treatment Of Alcohol Dependence Using Ibogaine And Derivatives Thereof App 20210145845 - MAILLET; Emeline ; et al.	2021-05-20
Methods And Compositions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloids App 20200352956 - Weis; Holger ; et al.	2020-11-12
Methods and compositions for potentiating the action of opioid analgesics using iboga alkaloids Grant 10,660,900 - Weis , et al.	2020-05-26
Methods And Compositions For Ibogaine Treatment Of Impulse Control Disorder, Anxiety-related Disorders, Violence And/or Anger, O App 20200093833 - Maillet; Emeline	2020-03-26
Methods For Acute And Long-term Treatment Of Alcohol Dependence Using Ibogaine And Derivatives Thereof App 20200085836 - Maillet; Emeline ; et al.	2020-03-19
Low Dose Noribogaine For Treating Nicotine Addiction And Preventing Relapse Of Nicotine Use App 20170368074 - Maillet; Emeline ; et al.	2017-12-28
Low dose noribogaine for treating nicotine addiction and preventing relapse of nicotine use Grant 9,561,232 - Maillet , et al. February 7, 2	2017-02-07
Methods And Compostions For Potentiating The Action Of Opioid Analgesics Using Iboga Alkaloids App 20160220579 - Weis; Holger ; et al.	2016-08-04
Methods And Compositions For Treating Impulse Control Disorder, Anxiety-related Disorders, Violence And/or Anger, Or Regulating Food Intake App 20160038505 - Maillet; Emeline ; et al.	2016-02-11
Methods And Compositions For Reducing Tolerance To Opioid Analgesics Using Ibogaine And Derivatives Thereof App 20150258111 - Maillet; Emeline ; et al.	2015-09-17
Methods And Compositions For Reducing Tolerance To Opioid Analgesics App 20150258108 - Maillet; Emeline ; et al.	2015-09-17
Low Dose Administration Of Ibogaine For Treating Nicotine Addiction And Preventing Relapse Of Nicotine Use App 20150258109 - Maillet; Emeline ; et al.	2015-09-17
Methods For Acute And Long-term Treatment Of Alcohol Dependence App 20150258105 - Maillet; Emeline ; et al.	2015-09-17
Methods For Acute And Long-term Treatment Of Alcohol Dependence Using Ibogaine App 20150258110 - Maillet; Emeline ; et al.	2015-09-17
Low Dose Noribogaine For Treating Nicotine Addiction And Preventing Relapse Of Nicotine Use App 20150238503 - Maillet; Emeline ; et al.	2015-08-27
Human Type I Taste Receptor Subunit 3 Modulators And Methods Of Using Same App 20120245213 - Mosinger; Bedrich ; et al.	2012-09-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.